ArticleMayo Clinic proceedings. Innovations, quality & outcomes2026
Patient Perspectives and Demographic Factors Influencing Non-Participation in a Large Genomics Study.
Article in Mayo Clinic proceedings. Innovations, quality & outcomes, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: To describe reasons why patients declined to participate in the Tapestry whole exome sequencing study and examine demographic trends in responses. Patients and Methods: The Tapestry study enrolled patients 18 years of age and over, beginning July 1, 2020, through May 31, 2024. This study includes 12,705 recruited subjects who declined to participate before February 14, 2022, but provided reasons for declination (RPs). RPs were selected from 5 discrete reasons for declination and had the opportunity to add a free-text comment. Comments were classified into 7 theme-based categories by the reviewers for analysis. Demographics of the subjects, including age, race, ethnicity, having a primary care provider, and rural-urban commuting area, were compared based on consent status and their reasons for declination. Results: RPs had a mean age of 61 years, were 90.1% White, and were 57.4% female. The most common reasons for declination were concerns about storing genetic data in electronic health records, the complexity of the process, and discomfort with genetic research. Significant differences in reasons for declination were found by sex, age, race, ethnicity, primary care provider status, and rural-urban commuting area. Conclusion: Our study highlights demographic and structural factors influencing genomic study non-participation. Distinct barriers were identified among active decliners, including privacy concerns, logistical issues, and mistrust. These findings emphasize the need for targeted education and provider engagement to support informed decision-making, reduce post-genomic sequencing regret, and promote equity in participation in large-scale personalized medicine initiatives.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.